13.49USD0.00%Mkt Cap: 3.54B $P/E: 14.511d ago
Organon & Co. develops and delivers women health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, China, Latin America, the Middle East, …
Industry Peers
Drug Manufacturers - General$1.04TUSDP/E 41.6
$601.73BUSDP/E 29.0
$449.42BUSDP/E 124.1
$305.83BUSDP/E 21.0
$315.22BUSDP/E 36.0
$272.16BUSDP/E 21.8
$268.42BUSDP/E 21.8
$243.51BUSDP/E 25.4
$216.37BUSDP/E 12.3
$212.87BUSDP/E 25.1
$200.54BUSDP/E 25.9
$169.23BUSDP/E 18.5
$143.28BUSDP/E 19.2
$123.57BUSDP/E 16.9
$100.10BUSDP/E 19.4
$85.16BUSDP/E 13.8
$50.96BUSD
$30.84BUSDP/E 22.4
MRV
Marvell Technology, Inc.$20.08BUSDP/E 7.4
$11.37BUSDP/E 22.7
$10.53BUSDP/E 18.3
$10.47BUSDP/E 18.2
$6.76BUSDP/E 15.0
$2.97BUSDP/E 18.1
$61.82MUSD
$39.24MUSD
ELXR
Elixxer Ltd.$9.51MUSD
FR0000140022
SANOFITP29OCT49—
CELG-RI
Bristol-Myers Squibb Company Ce—
FLXN
Horizon Flexible Income ETF—P/E 27.0
ROSE
DocMorris AG—
Indicators:|
| Headline | Source | Time |
|---|---|---|
This week | ||
 Organon & Co. (OGN) Is a Trending Stock: Facts to Know Before Betting on It Recently, Zacks.com users have been paying close attention to Organon (OGN). This makes it worthwhile to examine what the stock has in store. | ||
Older | ||